CHY.F

Healthcare Medical Devices

ChemoMetec A/S

€75.55
-2.50 -3.20% today

Price History

Not enough data

Key Stats

Market Cap
1.30B
Avg Volume
12
P/E (TTM)
48.74
EPS
€1.55
52W High
€106.60
52W Low
€33.74
Div. Yield
0.0%

Valuation

P/B Ratio
13.47
P/S Ratio
2.54
EV/EBITDA
3.96
EV/Revenue
2.06

Margins

Gross Margin 95.1%
Operating Margin 49.8%
Net Margin 39.5%
EBITDA Margin 52.0%

Growth & Returns

Revenue Growth (YoY)
7.4%
Earnings Growth (YoY)
51.3%
Earnings Growth (QoQ)
51.2%
Return on Equity
28.6%
Return on Assets
18.5%

Liquidity & Leverage

Current Ratio
4.09
Quick Ratio
3.06
Debt / Equity
0.01
Total Cash
293.56M
Total Debt
4.59M

About

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter NC-203, a high-precision cell counter designed to deliver complex cell samples; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops XcytoMatic 30 cell counter and Xcyto 5. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.

chemometec.com